Abbott Laboratories, US0028241000

Abbott Laboratories stock heads into the open after a 0.7 percent gain

Published on 09/22/2026 at 07:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, Abbott Laboratories stock stood at USD 102.61, up 0.7 percent on the NYSE. The S&P 500 gained 1.4 percent in the same session. A USD 385 million settlement and USD 0.63 dividend remain relevant today.

Modernes Diagnostik-Labor Abbott Laboratories US0028241000
Abbott Laboratories US0028241000 zeigt modernes Diagnostik-Labor mit Wissenschaftlern in weißen Laborkitteln an Analysesystemen, Illustration mit AI erstellt.

Abbott Laboratories stock closed at USD 102.61 on the NYSE on September 21, 2026, up 0.7 percent from the prior session. The S&P 500 rose 1.4 percent on the same date, outperforming the shares by 0.7 percentage points.

September 21, 2026 in numbers

Abbott Laboratories Inc. (ISIN US0028241000, NYSE: ABT) traded at USD 102.61 on September 21, 2026, according to the dated market summary. The shares were up 14.1 percent over three months from USD 89.90, while the prior NYSE close was USD 101.88 on September 18, 2026.

Legal developments also shaped the company specific news flow. As TradingView reported on September 21, 2026, Abbott agreed to a USD 385 million civil settlement and confirmed a quarterly dividend of USD 0.63 per share payable on November 16, 2026.

Settlement remains relevant today

The settlement concerns allegations linked to contaminated infant formula from the company plants in Sturgis and Casa Grande. The dividend payment date is November 16, 2026, while the settlement and legal exposure remain the immediate company specific items for the September 22 session.

Disclaimer...

en | US0028241000 | ABBOTT LABORATORIES | boerse | 70151103 | bgmi